Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Weider Namesake Brand To Feature New Products, Packaging In Late FY ’03

This article was originally published in The Tan Sheet

Executive Summary

Weider Nutrition International plans to revitalize its Weider brand and focus it more toward "body builder" consumers, the firm said during an Aug. 21 analyst call for the fourth quarter and year ended May 31

You may also be interested in...



Weider Planning “Total Relaunch” Of Core Brands In 2003

Weider Nutrition International will attempt to attract OTC and Rx drug users to its Move Free joint health supplement line as part of a "major relaunch" planned for the first half of 2003, President & CEO Bruce Wood said in a Dec. 19 analysts call

Weider Planning “Total Relaunch” Of Core Brands In 2003

Weider Nutrition International will attempt to attract OTC and Rx drug users to its Move Free joint health supplement line as part of a "major relaunch" planned for the first half of 2003, President & CEO Bruce Wood said in a Dec. 19 analysts call

Weider Planning “Total Relaunch” Of Core Brands In 2003

Weider Nutrition International will attempt to attract OTC and Rx drug users to its Move Free joint health supplement line as part of a "major relaunch" planned for the first half of 2003, President & CEO Bruce Wood said in a Dec. 19 analysts call

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094465

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel